Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
2.

Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Behar DM, Inbar O, Shteinberg M, Gur M, Mussaffi H, Shoseyov D, Ashkenazi M, Alkrinawi S, Bormans C, Hakim F, Mei-Zahav M, Cohen-Cymberknoh M, Dagan A, Prais D, Sarouk I, Stafler P, Bar Aluma BE, Akler G, Picard E, Aviram M, Efrati O, Livnat G, Rivlin J, Bentur L, Blau H, Kerem E, Singer A.

Mol Genet Genomic Med. 2017 Feb 19;5(3):223-236. doi: 10.1002/mgg3.278. eCollection 2017 May.

3.

Mutation of serine/threonine protein kinase 36 (STK36) causes primary ciliary dyskinesia with a central pair defect.

Edelbusch C, Cindrić S, Dougherty GW, Loges NT, Olbrich H, Rivlin J, Wallmeier J, Pennekamp P, Amirav I, Omran H.

Hum Mutat. 2017 Aug;38(8):964-969. doi: 10.1002/humu.23261. Epub 2017 Jun 15.

PMID:
28543983
4.

Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.

Amirav I, Roduta Roberts M, Mussaffi H, Mandelberg A, Roth Y, Abitbul R, Luder A, Blau H, Alkrinawi S, Aviram M, Ben-Ami M, Rotschild M, Bentur L, Shoseyov D, Cohen-Cymberknoh M, Kerem E, Avital A, Springer C, Hevroni A, Dabbah H, Elizur A, Picard E, Goldberg S, Rivlin J, Livnat G, Lavie M, Alias N, Soferman R, Olbrich H, Raidt J, Wallmeier J, Werner C, Loges NT, Omran H.

Version 2. F1000Res. 2016 Aug 18 [revised 2016 Jan 1];5:2031. eCollection 2016.

5.

Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices.

Abitbul R, Amirav I, Blau H, Alkrinawi S, Aviram M, Shoseyov D, Bentur L, Avital A, Springer C, Lavie M, Prais D, Dabbah H, Elias N, Elizur A, Goldberg S, Hevroni A, Kerem E, Luder A, Roth Y, Cohen-Cymberknoh M, Ben Ami M, Mandelberg A, Livnat G, Picard E, Rivlin J, Rotschild M, Soferman R, Loges NT, Olbrich H, Werner C, Wolter A, Herting M, Wallmeier J, Raidt J, Omran H, Mussaffi H.

Respir Med. 2016 Oct;119:41-47. doi: 10.1016/j.rmed.2016.08.015. Epub 2016 Aug 23.

6.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

7.

Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes.

Shteinberg M, Rivlin J, Gur M, Konopnicki M, Stein N, Tunney MM, Elborn JS, Downey DG, Johnston E, Shalom H, Levy A.

Lung. 2015 Dec;193(6):1017-21. doi: 10.1007/s00408-015-9801-z. Epub 2015 Sep 14.

PMID:
26370551
8.

[CYSTIC FIBROSIS SURVIVAL TRENDS IN CARMEL MEDICAL CENTER].

Nathan K, Shteinberg M, Rivlin J.

Harefuah. 2015 Jun;154(6):373-6, 404. Hebrew.

PMID:
26281081
9.

Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O.

World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.

10.

The unfolded protein response affects readthrough of premature termination codons.

Oren YS, McClure ML, Rowe SM, Sorscher EJ, Bester AC, Manor M, Kerem E, Rivlin J, Zahdeh F, Mann M, Geiger T, Kerem B.

EMBO Mol Med. 2014 May;6(5):685-701. doi: 10.1002/emmm.201303347.

11.

Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis.

Cohen-Cymberknoh M, Yaakov Y, Shoseyov D, Shteyer E, Schachar E, Rivlin J, Bentur L, Picard E, Aviram M, Israeli E, Kerem E, Wilschanski M.

Pediatr Pulmonol. 2013 Mar;48(3):229-35. doi: 10.1002/ppul.22586. Epub 2012 May 2.

PMID:
22553157
12.

Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis.

Kerem E, Wilschanski M, Miller NL, Pugatsch T, Cohen T, Blau H, Rivlin J, Shoseyov D, Reha A, Constantine S, Ajayi T, Hirawat S, Elfring GL, Peltz SW, Miller LL.

J Cyst Fibros. 2011 May;10(3):193-200. doi: 10.1016/j.jcf.2011.02.003. Epub 2011 Apr 2.

13.

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.

Wilschanski M, Miller LL, Shoseyov D, Blau H, Rivlin J, Aviram M, Cohen M, Armoni S, Yaakov Y, Pugatsch T, Cohen-Cymberknoh M, Miller NL, Reha A, Northcutt VJ, Hirawat S, Donnelly K, Elfring GL, Ajayi T, Kerem E.

Eur Respir J. 2011 Jul;38(1):59-69. doi: 10.1183/09031936.00120910. Epub 2011 Jan 13. Erratum in: Eur Respir J. 2011 Oct;38(4):996. Pugatch, T [corrected to Pugatsch, T].

14.

Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study.

Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J.

J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):173-8. doi: 10.1097/MPG.0b013e3181a3bfdd.

PMID:
19668004
15.

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, Nissim-Rafinia M, Blau H, Rivlin J, Aviram M, Elfring GL, Northcutt VJ, Miller LL, Kerem B, Wilschanski M.

Lancet. 2008 Aug 30;372(9640):719-27. doi: 10.1016/S0140-6736(08)61168-X. Epub 2008 Aug 20.

PMID:
18722008
16.

Nasal potential difference in non-classic cystic fibrosis-long term follow up.

Jaron R, Yaakov Y, Rivlin J, Blau H, Bentur L, Yahav Y, Kerem E, Bibi H, Picard E, Wilschanski M.

Pediatr Pulmonol. 2008 Jun;43(6):545-9. doi: 10.1002/ppul.20807.

PMID:
18433042
17.

Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.

Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, Yahav Y, Rahav G.

Emerg Infect Dis. 2008 Mar;14(3):378-84. doi: 10.3201/eid1403.061405.

18.

Hemoptysis in Israeli CF patients--prevalence, treatment, and clinical characteristics.

Efrati O, Harash O, Rivlin J, Bibi H, Meir MZ, Blau H, Mussaffi H, Barak A, Levy I, Vilozni D, Kerem E, Modan-Moses D.

J Cyst Fibros. 2008 Jul;7(4):301-6. doi: 10.1016/j.jcf.2007.11.007. Epub 2008 Jan 9.

19.

Reproducibility of nasal potential difference measurements in cystic fibrosis.

Yaakov Y, Kerem E, Yahav Y, Rivlin J, Blau H, Bentur L, Aviram M, Picard E, Bdolah-Abram T, Wilschanski M.

Chest. 2007 Oct;132(4):1219-26. Epub 2007 Sep 21.

PMID:
17890478
20.

Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.

Hakim F, Kerem E, Rivlin J, Bentur L, Stankiewicz H, Bdolach-Abram T, Wilschanski M.

J Pediatr Gastroenterol Nutr. 2007 Sep;45(3):347-53.

PMID:
17873748
21.

Chronic lung disease and cystic fibrosis phenotype in prolidase deficiency: a newly recognized association.

Luder AS, Mandel H, Khayat M, Gurevich I, Frankel P, Rivlin J, Falik-Zaccai TC.

J Pediatr. 2007 Jun;150(6):656-8, 658.e1.

PMID:
17517257
22.

Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia.

Feuk L, Kalervo A, Lipsanen-Nyman M, Skaug J, Nakabayashi K, Finucane B, Hartung D, Innes M, Kerem B, Nowaczyk MJ, Rivlin J, Roberts W, Senman L, Summers A, Szatmari P, Wong V, Vincent JB, Zeesman S, Osborne LR, Cardy JO, Kere J, Scherer SW, Hannula-Jouppi K.

Am J Hum Genet. 2006 Nov;79(5):965-72. Epub 2006 Sep 27.

23.

Paternal isodisomy of chromosome 7 with cystic fibrosis and overgrowth.

Fares F, David M, Lerner A, Diukman R, Lerer I, Abeliovich D, Rivlin J.

Am J Med Genet A. 2006 Aug 15;140(16):1785-8.

PMID:
16835920
24.

Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.

Efrati O, Mei-Zahav M, Rivlin J, Kerem E, Blau H, Barak A, Bujanover Y, Augarten A, Cochavi B, Yahav Y, Modan-Moses D.

J Pediatr Gastroenterol Nutr. 2006 Feb;42(2):222-8.

PMID:
16456419
25.

Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.

Falk B, Nini A, Zigel L, Yahav Y, Aviram M, Rivlin J, Bentur L, Avital A, Dotan R, Blau H.

Pediatr Pulmonol. 2006 Mar;41(3):234-41.

PMID:
16429430
26.
27.

Trampoline use as physiotherapy for cystic fibrosis patients.

Barak A, Wexler ID, Efrati O, Bentur L, Augarten A, Mussaffi H, Avital A, Rivlin J, Aviram M, Yahav Y, Kerem E.

Pediatr Pulmonol. 2005 Jan;39(1):70-3. Review.

PMID:
15532080
28.

Familial concordance of phenotype and microbial variation among siblings with CF.

Picard E, Aviram M, Yahav Y, Rivlin J, Blau H, Bentur L, Avital A, Villa Y, Schwartz S, Kerem B, Kerem E.

Pediatr Pulmonol. 2004 Oct;38(4):292-7.

PMID:
15334505
29.

Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.

Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem BS, Theodor L, Paret G, Yahav Y.

Clin Exp Med. 2003 Sep;3(2):119-23.

PMID:
14598187
30.

Role of hydrogen peroxide in sperm capacitation and acrosome reaction.

Rivlin J, Mendel J, Rubinstein S, Etkovitz N, Breitbart H.

Biol Reprod. 2004 Feb;70(2):518-22. Epub 2003 Oct 15.

PMID:
14561655
31.

Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E.

N Engl J Med. 2003 Oct 9;349(15):1433-41.

32.

Remodeling of the actin cytoskeleton during mammalian sperm capacitation and acrosome reaction.

Brener E, Rubinstein S, Cohen G, Shternall K, Rivlin J, Breitbart H.

Biol Reprod. 2003 Mar;68(3):837-45.

PMID:
12604633
33.

Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients.

Augarten A, Akons H, Aviram M, Bentur L, Blau H, Picard E, Rivlin J, Miller MS, Katznelson D, Szeinberg A, Shmilovich H, Paret G, Laufer J, Yahav Y.

Pediatr Transplant. 2001 Oct;5(5):339-42.

PMID:
11560752
34.

Nasal potential difference measurements in patients with atypical cystic fibrosis.

Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, Bentur L, Yahav Y, Springer H, Kramer MR, Klar A, Ilani A, Kerem B, Kerem E.

Eur Respir J. 2001 Jun;17(6):1208-15.

35.

Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests.

Augarten A, Shmilovich H, Doolman R, Aviram M, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Sela BA, Szeinberg A, Yahav Y.

Pediatr Pulmonol. 2000 Oct;30(4):320-3.

PMID:
11015133
36.

A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations.

Wilschanski M, Famini C, Blau H, Rivlin J, Augarten A, Avital A, Kerem B, Kerem E.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):860-5.

PMID:
10712334
37.

Cystic fibrosis mutations in Israeli Arab patients.

Laufer-Cahana A, Lerer I, Sagi M, Rachmilewitz-Minei T, Zamir C, Rivlin JR, Abeliovich D.

Hum Mutat. 1999 Dec;14(6):543.

PMID:
10571955
38.
39.

Clinical and genetic risk factors for cystic fibrosis-related liver disease.

Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, Bentur L, Springer C, Vila Y, Branski D, Kerem B, Kerem E.

Pediatrics. 1999 Jan;103(1):52-7.

PMID:
9917439
40.

Adhesion-related abdominal wall varices: demonstration by color Doppler sonography.

Barzilai M, Lerner A, Rivlin J.

AJR Am J Roentgenol. 1998 Jun;170(6):1670. No abstract available.

PMID:
9609200
41.

Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis.

Rivlin J, Lerner A, Augarten A, Wilschanski M, Kerem E, Ephros MA.

J Pediatr. 1998 Jan;132(1):177-9.

PMID:
9470027
42.

A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.

Kerem E, Rave-Harel N, Augarten A, Madgar I, Nissim-Rafinia M, Yahav Y, Goshen R, Bentur L, Rivlin J, Aviram M, Genem A, Chiba-Falek O, Kraemer MR, Simon A, Branski D, Kerem B.

Am J Respir Crit Care Med. 1997 Jun;155(6):1914-20.

PMID:
9196095
43.

Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.

Kerem E, Kalman YM, Yahav Y, Shoshani T, Abeliovich D, Szeinberg A, Rivlin J, Blau H, Tal A, Ben-Tur L, et al.

Hum Genet. 1995 Aug;96(2):193-7.

PMID:
7635469
44.

[Flexible bronchoscopy in the diagnosis of foreign body aspiration].

Uri N, Rivlin J, Greenberg E.

Harefuah. 1995 May 1;128(9):536-7, 600, 599. Hebrew.

PMID:
7797150
45.

Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.

Shoshani T, Kerem E, Szeinberg A, Augarten A, Yahav Y, Cohen D, Rivlin J, Tal A, Kerem B.

J Clin Invest. 1994 Apr;93(4):1502-7.

46.

Ciliary ultrastructure in primary ciliary dyskinesia and other chronic respiratory conditions: the relevance of microtubular abnormalities.

Lurie M, Rennert G, Goldenberg S, Rivlin J, Greenberg E, Katz I.

Ultrastruct Pathol. 1992 Sep-Oct;16(5):547-53.

PMID:
1440977
47.

[New aspects of cystic fibrosis liver disease].

Lerner A, Rivlin J.

Harefuah. 1992 May 1;122(9):593-4. Review. Hebrew. No abstract available.

PMID:
1526587
48.

The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs.

Lerer I, Cohen S, Chemke M, Sanilevich A, Rivlin J, Golan A, Yahav J, Friedman A, Abeliovich D.

Hum Genet. 1990 Sep;85(4):416-7.

PMID:
1976595
49.
50.

Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients.

Lahat N, Rivlin J, Iancu TC.

J Clin Immunol. 1989 Jul;9(4):287-95.

PMID:
2527866

Supplemental Content

Loading ...
Support Center